(Q35765058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sandro Iannaccone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Stefano Cappa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

Chiara Cerami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

Roberto Santangelo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

Elisabetta Coppi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

7

Patrizia Pinto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

8

Gabriella Passerini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

13

Luigi Gianolli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

12

Giancarlo Comi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Daniela Perani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Silvia Paola Caminiti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Laura Ferrari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Giuseppe Magnani

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

4 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

499-508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26341365%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-015-3170-y

23 February 2020

exact match

0 references

cites work

Implications of early treatment among Medicaid patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Classification of primary progressive aphasia and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Criteria for the diagnosis of corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Age, Alzheimer disease, and brain structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

FDG-PET and amyloid-PET imaging: the diverging paths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Practical utility of amyloid and FDG-PET in an academic dementia center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Impact of molecular imaging on the diagnostic process in a memory clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Imaging markers for Alzheimer disease: which vs how

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Multimodal classification of Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Cognition and anatomy in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Hippocampal atrophy in Alzheimer disease: age matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3170-Y

Functional neuroimaging of cognition

21 January 2018

1 reference

12 December 2020

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients

1 reference

12 December 2020

Brain changes within the visuo-spatial attentional network in posterior cortical atrophy.

1 reference

12 December 2020

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

1 reference

12 December 2020

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease

1 reference

12 December 2020

Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia

1 reference

12 December 2020

Alzheimer's disease and the frontotemporal dementias: contributions to clinico-pathological studies, diagnosis, and cognitive neuroscience

1 reference

12 December 2020

Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy

1 reference

12 December 2020

Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia

1 reference

12 December 2020